Alivus Life Sciences Ltd (ALIV)

Currency in INR
1,016.45
-11.05(-1.08%)
Closed·
ALIV Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
ALIV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,010.001,048.95
52 wk Range
827.101,335.00
Key Statistics
Bid/Ask
1,015.00 / 1,024.20
Prev. Close
1,027.5
Open
1,048.95
Day's Range
1,010-1,048.95
52 wk Range
827.1-1,335
Volume
3.8K
Average Volume (3m)
4.55K
1-Year Change
20.78%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALIV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Alivus Life Sciences Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Alivus Life Sciences Ltd Company Profile

Alivus Life Sciences Limited engages in the development, manufacture, and marketing of non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company offers various APIs, such as olmesartan, telmisartan, perindopril, atovaquone, solifenacin, mirabegron, sitagliptin, zonisamide, adapalene, and rosuvastatin. It also provides contract development and manufacturing services to a range of multinational corporations and specialty companies. The company’s APIs are used in various therapeutic segments, including cardiovascular disease, central nervous system disorders, diabetes, gastrointestinal health, oncology, pain management, and anti-infectives. It also exports its products to Europe, North America, Latin America, Japan, and internationally. The company was formerly known as Glenmark Life Sciences Limited and changed its name to Alivus Life Sciences Limited in December 2024. The company was incorporated in 2011 and is based in Mumbai, India. Alivus Life Sciences Limited is a subsidiary of Nirma Limited.

Employees
2014
Market
India

Compare ALIV to Peers and Sector

Metrics to compare
ALIV
Peers
Sector
Relationship
P/E Ratio
25.8x28.8x−0.5x
PEG Ratio
8.690.500.00
Price/Book
4.4x3.0x2.6x
Price / LTM Sales
5.3x3.1x3.2x
Upside (Analyst Target)
29.8%8.3%41.2%
Fair Value Upside
Unlock2.7%6.2%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
11.60 / --
Revenue / Forecast
6.50B / --
EPS Revisions
Last 90 days

ALIV Income Statement

People Also Watch

2,632.10
ANGO
+0.92%
388.25
BAJE
-0.26%
425.80
HPCL
+0.92%
242.26
BOB
+0.80%
252.35
ADTB
-0.55%

FAQ

What Stock Exchange Does Alivus Life Sciences Ltd Trade On?

Alivus Life Sciences Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Alivus Life Sciences Ltd?

The stock symbol for Alivus Life Sciences Ltd is "ALIV."

What Is the Alivus Life Sciences Ltd Market Cap?

As of today, Alivus Life Sciences Ltd market cap is 125.33B.

What Is Alivus Life Sciences Ltd's Earnings Per Share (TTM)?

The Alivus Life Sciences Ltd EPS (TTM) is 39.63.

When Is the Next Alivus Life Sciences Ltd Earnings Date?

Alivus Life Sciences Ltd will release its next earnings report on 16 Oct 2025.

From a Technical Analysis Perspective, Is ALIV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Alivus Life Sciences Ltd Stock Split?

Alivus Life Sciences Ltd has split 0 times.

How Many Employees Does Alivus Life Sciences Ltd Have?

Alivus Life Sciences Ltd has 2014 employees.

What is the current trading status of Alivus Life Sciences Ltd (ALIV)?

As of 29 Jul 2025, Alivus Life Sciences Ltd (ALIV) is trading at a price of 1,016.45, with a previous close of 1,027.50. The stock has fluctuated within a day range of 1,010.00 to 1,048.95, while its 52-week range spans from 827.10 to 1,335.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.